search

Active clinical trials for "Syndrome"

Results 4281-4290 of 9759

Clofarabine in High Risk Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndrome

This study aims to determine the maximal tolerated dose (MTD) and dose limiting toxicities (DLTs) of low dose IV clofarabine for MDS patients after treatment failure of azacitidine.

Completed21 enrollment criteria

A Safety and Efficacy Study of 552-02 in Subjects With Dry Mouth Associated With Sjogren's Syndrome...

Dry Mouth Associated With Sjogren's SyndromeXerostomia

This clinical study is to determine whether daily administration of a formulation of 552-02 improves the dry mouth condition in subjects with primary Sjögren's syndrome.

Completed25 enrollment criteria

A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Children...

DCild Development DisordersPervasive4 more

The purpose of the study is to evaluate the effectiveness of an oral solution of risperidone (an antipsychotic medication) versus placebo in the treatment of behavioral symptoms in children with Pervasive Developmental Disorders (PDD).

Completed9 enrollment criteria

Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone...

Inappropriate ADH SyndromeHyponatremia

To determine the long-term safety and tolerability of SR121463B in patients with syndrome of inappropriate antidiuretic secretion (SIADH). To assess the long-term efficacy of SR121463B in maintaining normal levels of serum sodium in patients with SIADH. Long term safety is evaluated further in an open label extension study with flexible doses of satavaptan.

Completed17 enrollment criteria

The Effects of Aripiprazole on Patients With Metabolic Syndrome

SchizophreniaSchizoaffective Disorder2 more

The primary goal of this study is to assess the effect of aripiprazole on patients who developed metabolic syndrome while taking other second generation antipsychotic medications.

Completed9 enrollment criteria

The Study of the Safety and Efficacy of Ampligen in Chronic Fatigue Syndrome

Chronic Fatigue SyndromeMyalgic Encephalomyelitis

multi-center, double-blind, randomized, placebo-controlled study of the safety and efficacy.

Completed9 enrollment criteria

Evaluation of the Efficacy and Safety of Recombinant Human Growth Hormone (rhGH) in the Treatment...

Short Bowel Syndrome

This is a randomized controlled, parallel group, open label versus "no treatment" trial which evaluate the efficacy of rhGH on weaning off parenteral nutrition in children with short bowel syndrome.The total follow-up is 14 months; 4 months for each group after randomization; At the end of the first four months: the treated group will be followed within 6 months, the untreated group will receive compassionately rhGH for 4 months and followed-up for 6 months after the end of the treatment period.

Completed8 enrollment criteria

Post-Poliosyndrome Treated With Intravenous Immunoglobulin (IvIg)

Post-Polio Syndrome

Inflammatory cytokines in the cerebrospinal fluid may contribute to the new muscle weakness, fatigue and pain experienced by patients with post-polio syndrome. Intravenousimmunoglobulin (IvIg) reduces this inflammation. The purpose of this study is to investigate the clinical effect of IvIg in post-polio syndrome.

Completed2 enrollment criteria

Effect of Positive Expiratory Pressure on Right Ventricular Function in Patients With Respiratory...

Respiratory Distress SyndromeAdult

The objective of this study is to analyze by trans-oesophageal echocardiography the effect on the right ventricle of positive expiratory pressure (PEP) level variations with constant plate pressure among patients with syndrome of acute respiratory distress of the adult (SDRA). The assumption tested is that a high level of PEP increases the impedance with the ejection of the right ventricle independently of the level of plate pressure. The effect on the right ventricular preload will be checked via the analysis of the respiratory variability of the diameter of the higher vena cava.

Completed14 enrollment criteria

A Study of YM060 in Diarrhea-predominant Irritable Bowel Syndrome (d-IBS)

Irritable Bowel Syndrome

This study will examine the efficacy, safety and tolerability of different oral dose of YM060, 5-HT3 receptor antagonist, in patients with d-IBS.

Completed3 enrollment criteria
1...428429430...976

Need Help? Contact our team!


We'll reach out to this number within 24 hrs